The Mahayuti alliance, led by BJP, has crossed the majority mark of 114 based in trends. As the BMC result counting continues ...
UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as 'The weapon to end the virus war.' - Announces ...
Invivyd has launched its DECLARATION Phase 3 pivotal trial for VYD2311, a monoclonal antibody designed as an alternative to ...
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
It comes after weeks of criticism from pub bosses, industry chiefs and politicians over changes to business rates in the ...
Here's what you need to know about this season's H3N2 flu symptoms, treatment, when to go to the hospital and whether to get ...
BioNTech with continued late-stage pipeline progress with candidates across immunomodulators, antibody-drug conjugates and mRNA immunotherapiesExpected 2026 oncology ...
Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback